galactosamine has been researched along with Lupus Erythematosus, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahjat, FR; Blenman, KR; Moldawer, LL; Morel, L | 1 |
| Cheng, CY; Lahita, R; Mo, MY; Mruk, D; Panzironi, C; Silvestrini, B | 1 |
2 other study(ies) available for galactosamine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Aberrant signaling in the TNFalpha/TNF receptor 1 pathway of the NZM2410 lupus-prone mouse.
Topics: Animals; Antigens, CD; Apoptosis; Aspartate Aminotransferases; Caspase 3; Caspases; Cytotoxicity Tests, Immunologic; Female; Galactosamine; In Situ Nick-End Labeling; Interleukin-10; Interleukin-6; Lipopolysaccharides; Liver; Lupus Erythematosus, Systemic; Male; Mice; Mice, Congenic; Mice, Inbred C57BL; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Tumor Necrosis Factor-alpha | 2004 |
An increase in the carbohydrate moiety of alpha 2-macroglobulin is associated with systemic lupus erythematosus (SLE).
Topics: alpha-Macroglobulins; Antibodies; Carbohydrates; DNA; Female; Galactosamine; Galactose; Glucosamine; Glucose; Humans; Lupus Erythematosus, Systemic; Male; Mannose | 1997 |